Haematology

Doç. Dr. Sevil Sadri

Doctor and researcher İstanbul Eğitim Araştırma Hastanesi İstanbul
Leukemia, Myelogenous, Chronic, BCR-ABL PositiveOsteoporosisThrombosisPurpura, Thrombocytopenic, IdiopathicHemophilia AHemophilia B
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Osteoporosis 2 publications
  • Thrombosis 2 publications
  • Purpura, Thrombocytopenic, Idiopathic 2 publications
  • Hemophilia A 2 publications
  • Hemophilia B 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyHaematologysaglik.gov.trFrom source
  • Institutionİstanbul Eğitim Araştırma Hastanesisaglik.gov.trFrom source
  • Area of workLeukemia, Myelogenous, Chronic, BCR-ABL PositiveExtracted from 4 publications · Model version —From source
  • Publications64 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0002-6315-9620ORCIDFrom source
  • Last synchronised5 November 2026 08:56https://istanbuleah.saglik.gov.tr/TR-1039593/doktorlar.html#sevil-sadrisaglik.gov.tr

Scientific work

Publications on Leukemia, Myelogenous, Chronic, BCR-ABL Positive

64 publications

  1. Evaluation of the frequency, risk factors, and outcomes of splanchnic vein thrombosis in myeloproliferative neoplasms: a retrospective cohort study

    Journal of Thrombosis and Thrombolysis, 2026

    DOI 10.1007/s11239-026-03363-8 PMID 42565930 Open-access full textSource: OpenAlex

  2. Time-Dependent Prognostic Value of the mEASIX Score in Patients with Myelodysplastic Syndromes

    Diagnostics, 2026

    DOI 10.3390/diagnostics16111640 PMID 42279509 Open-access full textSource: ORCID

  3. Association of the Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score With Renal Recovery in Newly Diagnosed Multiple Myeloma: A Retrospective Study

    The European Research Journal, 2026

    DOI 10.18621/eurj.1399 Open-access full textSource: ORCID

  4. Eltrombopag for Chemotherapy-Induced Thrombocytopenia: A Multicenter Retrospective Real-World Study

    Hematology Reports, 2026

    DOI 10.3390/hematolrep18030039 PMID 42345735 Open-access full textSource: ORCID

  5. Evaluation of Dermatological Lesions in Patients With Hematologic Malignancy

    Uludağ Üniversitesi Tıp Fakültesi Dergisi, 2026

    DOI 10.32708/uutfd.1782776 Open-access full textSource: ORCID

  6. Probable sarcopenia and bone health in transfusion-dependent beta thalassemia patients

    Hematology, 2026

    DOI 10.1080/16078454.2026.2712127 PMID 42550149 Open-access full textSource: OpenAlex

  7. Clinical practice of the endothelial activation and stress index and its modified versions in multiple myeloma and the effects on prognosis

    Therapeutic Advances in Hematology, 2026

    DOI 10.1177/20406207251387409 PMID 41509514 5 citations (OpenAlex) Open-access full textSource: OpenAlex

  8. Kaposi Sarcoma Presenting as Hemophagocytic Lymphohistiocytosis Mimicking Infection and Lymphoma: A Diagnostic Challenge

    Cureus, 2026

    DOI 10.7759/cureus.105780 PMID 42037832 Open-access full textSource: OpenAlex

  9. PB1736 A single-center retrospective study of thrombosis and procedural outcomes in hospitalized patients receiving therapeutic plasma exchange

    Research and Practice in Thrombosis and Haemostasis, 2026

    DOI 10.1016/j.rpth.2026.104598 Open-access full textSource: OpenAlex

  10. MİYELOPROLİFERATİF NEOPLAZMLARDA SPLANKNİK VEN TROMBOZUNUN DEĞERLENDİRİLMESİ: THD KRONİK MİYELOSİTER LÖSEMİ VE KRONİK MİYELOPROLİFERATİF NEOPLAZMLAR VE HEMOSTAZ - TROMBOZ BİLİMSEL ALT KOMİTELERİ ÇOK MERKEZ ÇALIŞMASI

    Kocaeli Üniversitesi - AVESİS, 2025

    Source: OpenAlex

View all 64 publications